Marinus Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '25 Feb 11, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021	Sep '20 Sep 30, 2020
Market Capitalization	19	11	11	10	13	21
Market Cap Growth	-99.42%	1.15%	17.79%	-27.78%	-36.69%	39.71%
Enterprise Value	21	27	23	28	24	39
Last Close Price	0.25	0.15	0.13	0.10	0.14	0.22
PE Ratio	34.60	-	2.24	7.53	-	73.92
PS Ratio	0.38	0.29	0.29	0.32	0.37	0.54
PB Ratio	1.34	1.13	0.83	0.79	0.90	1.33
P/TBV Ratio	1.34	1.13	0.83	0.79	0.90	1.33
P/FCF Ratio	1.62	-	1.80	-	-	16.81
P/OCF Ratio	1.58	-	1.69	-	-	7.85
EV/Sales Ratio	0.42	0.69	0.60	0.93	0.69	1.00
EV/EBITDA Ratio	9.02	12.47	3.19	8.22	8.63	16.23
EV/EBIT Ratio	13.54	17.24	3.48	10.43	12.73	26.93
EV/FCF Ratio	1.80	-	3.70	-	-	31.19
Debt / Equity Ratio	0.63	1.15	0.15	0.85	0.96	0.61
Debt / EBITDA Ratio	3.00	4.86	0.27	2.90	4.51	3.80
Debt / FCF Ratio	0.76	-	0.32	-	-	7.68
Asset Turnover	1.35	1.53	1.66	1.11	1.09	1.06
Inventory Turnover	2.94	5.68	6.95	5.02	12.23	8.70
Quick Ratio	0.55	0.30	0.94	0.31	0.69	1.06
Current Ratio	1.35	1.05	1.60	0.92	1.04	1.27
Return on Equity (ROE)	3.89%	-24.00%	43.54%	11.03%	-0.59%	1.87%
Return on Assets (ROA)	3.70%	3.84%	18.02%	6.17%	3.69%	2.45%
Return on Invested Capital (ROIC)	4.75%	5.29%	24.95%	7.72%	4.50%	3.16%
Return on Capital Employed (ROCE)	12.50%	11.60%	37.00%	17.00%	8.70%	5.80%
Earnings Yield	2.86%	-25.34%	44.68%	13.28%	-0.67%	1.35%
FCF Yield	61.77%	-100.11%	55.44%	-25.42%	-30.25%	5.95%
Dividend Yield	4.28%	2.48%	19.33%	2.55%	4.06%	2.16%
Payout Ratio	46.57%	-	22.41%	13.83%	-	209.26%
Buyback Yield / Dilution	0.10%	-	-	-1.02%	1.01%	-
Total Shareholder Return	0.10%	2.48%	19.33%	1.53%	5.07%	2.16%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q